These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33682491)

  • 1. Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models.
    Liang H; Hu C; Lu J; Zhang T; Jiang J; Ding D; Du S; Duan S
    J Int Med Res; 2021 Mar; 49(3):300060521997586. PubMed ID: 33682491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
    Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
    World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
    Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
    Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features.
    Li J; Xue F; Xu X; Wang Q; Zhang X
    Exp Ther Med; 2020 Oct; 20(4):3643-3652. PubMed ID: 32855716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.
    Wang B; Gao ZQ; Yan X
    Acta Radiol; 2005 Jul; 46(4):353-8. PubMed ID: 16134309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma.
    Chen Y; Qin X; Long L; Zhang L; Huang Z; Jiang Z; Li C
    J Magn Reson Imaging; 2020 Jun; 51(6):1755-1763. PubMed ID: 31675163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
    Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
    Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.
    Ahn SJ; An CS; Koom WS; Song HT; Suh JS
    Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-level dynamic spiral CT of hepatocellular carcinoma: correlation between imaging features and density of tumor microvessels.
    Chen WX; Min PQ; Song B; Xiao BL; Liu Y; Ge YH
    World J Gastroenterol; 2004 Jan; 10(1):67-72. PubMed ID: 14695771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlation of computed tomography perfusion and histopathology in tumor edges of hepatocellular carcinoma.
    Bai RJ; Li JP; Ren SH; Jiang HJ; Liu XD; Ling ZS; Huang Q; Feng GL
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):612-7. PubMed ID: 25475863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Study of the Correlation of Perfusion Parameters in High-Resolution GRASP MRI With Microvascular Density in Lung Cancer.
    Chen L; Zeng X; Wu Y; Yan X; Huang X; Chen H; Zhang J; Wang J; Feng L
    J Magn Reson Imaging; 2019 Apr; 49(4):1186-1194. PubMed ID: 30390364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology.
    Xiao JD; Zhu WH; Shen SR
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):605-10. PubMed ID: 21134829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
    Zhang W; Chen HJ; Wang ZJ; Huang W; Zhang LJ
    Eur Radiol; 2017 May; 27(5):2086-2094. PubMed ID: 27488851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation.
    Lin CC; Cheng YF; Chiang HJ; Lazo M; Chang CD; Tsang LL; Yu CY; Hsu HW; Chen WT; Wang CC; Liang JL; Eng HL; Chen CL; Ou HY
    Transplant Proc; 2016 May; 48(4):1041-4. PubMed ID: 27320551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the potential use of dynamic contrast-enhanced (DCE) MRI parameters as radiomic features of cervical cancer.
    Lu Y; Peng W; Song J; Chen T; Wang X; Hou Z; Yan Z; Koh TS
    Med Phys; 2019 Nov; 46(11):5098-5109. PubMed ID: 31523829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvessel density of malignant and benign hepatic lesions and MRI evaluation.
    Lu JP; Wang J; Wang T; Wang Y; Wu WQ; Gao L
    World J Gastroenterol; 2004 Jun; 10(12):1730-4. PubMed ID: 15188495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma.
    Wang Z; Tang J; An L; Wang W; Luo Y; Li J; Xu J
    J Ultrasound Med; 2007 Jun; 26(6):757-62. PubMed ID: 17526607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.